Mon, Dec 22, 2014, 9:14 AM EST - U.S. Markets open in 16 mins.


% | $
Quotes you view appear here for quick access.

Amicus Therapeutics, Inc. (FOLD) Message Board

  • jrdelane jrdelane Jan 18, 2013 12:37 AM Flag

    What happened today, was it the announcement of the 149 million share financing that spooked?

    I haven't seen any mention of it here, so it's the elephant in the room I am addressing. I liked the share price mentioned but that doesn't have any meaning, it was historical just to see the fee structure for the offering, which isn't timed as yet, nor priced. Your thoughts?

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It's a shelf registration - most biotech companies have them - there is no expectation they are going to do an offering over the next year, as they have enough cash to get them to at least the 2nd half of 2014. BTW - the shelf is not for 149M shares - it is a targeted $149M of proceeds. Shelf registrations target proceed amounts that are typically 3-5 times higher than what the company would raise in a single offering. No news here.

8.03Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.